It means index funds tracking the ASX300 will buy some Nearmap in a weighting matching their weighting in the index. Usually, it means a jump in the share price leading up to the date.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025